Owners, management and financials
CVR: 37852406
Previous names: ResoTher Pharma ApS
Not available
Quantass ApS (5-9,99%), TJ Biotech Holding ApS (5-9,99%)
CVR · view owners
Anders Kronborg
Board: Rebecca Anne Morison (chair) and 6 members
CVR · view management
Active
Founded 4 July 2016
CVR · view overview
2 employees
CVR · 2018
Director registered: Anders Kronborg
CVR · 01/02/2023
View the full event history
ResoTher Pharma A/S is a Danish company of the type Aktieselskab based in Holte, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ResoTher Pharma ApS. The management consists of Anders Kronborg. The board consists of Rebecca Anne Morison (chair), Henrik Stage, Jeppe Øvli Øvlesen and Michael Østerlund Madsen. The company is owned by Quantass ApS and TJ Biotech Holding ApS. The company has 2 employees (2018). Equity in the 2025 report amounted to DKK 12,132,000.
Selskabet har til formål at gennemføre forskning i og udvikling af peptidbaserede lægemidler rettet mod inflammation, forprogrammeret celledød, cancer samt koagulerings- og blodlegmesygdomme, med særlig fokus på Annexin A1-deriverede peptider; at foretage investeringer i interesser, som gennemfører tilsvarende aktiviteter, herunder i immaterielle rettigheder knyttet til sådanne; og at gennemføre med lægemiddeludvikling relaterede aktiviteter.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | - | 16.4 mio. | 12.1 mio. | 3 | |
| 202401/01/2024 – 31/12/2024 | - | -10.1 mio. | 14.8 mio. | 12.1 mio. | - | |
| 202301/01/2023 – 31/12/2023 | - | - | 21.8 mio. | 20.8 mio. | 2 | |
| 202201/01/2022 – 31/12/2022 | - | -27.2 mio. | 18 t. | 12.2 mio. | 3 | |
| 202101/01/2021 – 31/12/2021 | - | -11.7 mio. | 41.4 mio. | 38.6 mio. | 3 | |
| 202001/01/2020 – 31/12/2020 | - | -5.2 mio. | 4.5 mio. | -560 t. | 2 | |
| 201901/01/2019 – 31/12/2019 | - | -3.9 mio. | 5.4 mio. | 1.7 mio. | - | |
| 201801/01/2018 – 31/12/2018 | -2.1 mio. | -2.4 mio. | 1 mio. | -1.5 mio. | 1 |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of ResoTher Pharma A/S is 37852406.
ResoTher Pharma A/S is owned by Quantass ApS and TJ Biotech Holding ApS.
The management of ResoTher Pharma A/S consists of Anders Kronborg.
The board of ResoTher Pharma A/S consists of Rebecca Anne Morison, Henrik Stage and Jeppe Øvli Øvlesen, with Rebecca Anne Morison as chair.
ResoTher Pharma A/S had 2 employees in 2018 according to the Danish CVR register.
ResoTher Pharma A/S was founded on 4 July 2016.
Claim this page to add your logo and social links. Free to get started.
ResoTher Pharma A/S has published its annual report for 2025.
Contact info changed: new email: [email protected] (July 2, 2026).
As of June 29, 2026, Michael Østerlund Madsen has joined the board of directors of ResoTher Pharma A/S.
Contact info changed: new email: [email protected] (May 22, 2026).
Contact info changed: new email: [email protected] (April 10, 2026).
Contact info changed: new email: [email protected] (January 21, 2026).
As of December 15, 2025, Thomas Engelbrecht Nordkild Jonassen has joined the board of directors of ResoTher Pharma A/S.
As of December 15, 2025, Rebecca Anne Morison has joined the board of directors of ResoTher Pharma A/S.
As of December 14, 2025, Thomas Engelbrecht Nordkild Jonassen has left the board of directors of ResoTher Pharma A/S.
As of December 14, 2025, Rebecca Anne Morison has left the board of directors of ResoTher Pharma A/S.
As of September 23, 2025, Rebecca Anne Morison has joined the board of directors of ResoTher Pharma A/S.
ResoTher Pharma A/S has published its annual report for 2024. The net result was DKK -10,071,000.
As of June 23, 2025, Thomas Engelbrecht Nordkild Jonassen has joined the board of directors of ResoTher Pharma A/S.
As of June 23, 2025, Kirsten Aarup Drejer has left the board of directors of ResoTher Pharma A/S.
As of June 23, 2025, Thomas Feldthus has left the board of directors of ResoTher Pharma A/S.
ResoTher Pharma A/S has published its annual report for 2023.
ResoTher Pharma A/S has published its annual report for 2022. The net result was DKK -27,218,000.
As of June 28, 2023, Roderick John Flower has joined the board of directors of ResoTher Pharma A/S.
As of February 1, 2023, Anders Kronborg is registered as adm. dir. of ResoTher Pharma A/S.
As of January 31, 2023, Lone Merete Veng has stepped down as adm. dir. of ResoTher Pharma A/S.
ResoTher Pharma A/S has published its annual report for 2021. The net result was DKK -11,678,000.
On May 18, 2022, the company changed its name from ResoTher Pharma ApS to ResoTher Pharma A/S.
As of December 15, 2021, Quantass ApS is registered as an owner of ResoTher Pharma A/S with an ownership share of 5%.
As of December 15, 2021, TJ Biotech Holding ApS is registered as an owner of ResoTher Pharma A/S with an ownership share of 5%.
ResoTher Pharma A/S has published its annual report for 2020. The net result was DKK -5,196,000.
As of May 31, 2021, Thomas Feldthus has joined the board of directors of ResoTher Pharma A/S.
As of May 31, 2021, Sven Martin Jacobson has joined the board of directors of ResoTher Pharma A/S.
As of May 31, 2021, Lars Henning Stigel has left the board of directors of ResoTher Pharma A/S.
ResoTher Pharma A/S has published its annual report for 2019. The net result was DKK -3,916,000.
ResoTher Pharma A/S has published its annual report for 2018. Gross profit came to DKK -2,070,952, and the net result was DKK -2,412,666.
As of May 29, 2019, EY Godkendt Revisionspartnerselskab has been appointed auditor of ResoTher Pharma A/S.
As of May 29, 2019, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ResoTher Pharma A/S.
As of May 29, 2019, Lars Henning Stigel has joined the board of directors of ResoTher Pharma A/S.
As of May 29, 2019, Mette Munch has left the board of directors of ResoTher Pharma A/S.
As of July 11, 2018, Jeppe Øvli Øvlesen has joined the board of directors of ResoTher Pharma A/S.
As of July 11, 2018, Kirsten Aarup Drejer has joined the board of directors of ResoTher Pharma A/S.
As of July 10, 2018, Jeppe Øvli Øvlesen has left the board of directors of ResoTher Pharma A/S.
As of July 10, 2018, Kirsten Aarup Drejer has left the board of directors of ResoTher Pharma A/S.
ResoTher Pharma A/S has published its interim report for the period July 4, 2016 – December 31, 2017.
As of April 30, 2018, Kirsten Aarup Drejer has joined the board of directors of ResoTher Pharma A/S.
As of November 23, 2017, Henrik Stage has joined the board of directors of ResoTher Pharma A/S.
As of November 23, 2017, Mette Munch has joined the board of directors of ResoTher Pharma A/S.
As of November 23, 2017, Thomas Engelbrecht Nordkild Jonassen has left the board of directors of ResoTher Pharma A/S.
As of November 23, 2017, Lone Merete Veng has left the board of directors of ResoTher Pharma A/S.
As of November 23, 2017, Lone Merete Veng is registered as adm. dir. of ResoTher Pharma A/S.
As of November 23, 2017, Thomas Engelbrecht Nordkild Jonassen has stepped down as adm. dir. of ResoTher Pharma A/S.
As of October 26, 2017, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ResoTher Pharma A/S.
As of April 19, 2017, Lone Merete Veng has joined the board of directors of ResoTher Pharma A/S.
As of July 4, 2016, Jeppe Øvli Øvlesen has joined the board of directors of ResoTher Pharma A/S.
As of July 4, 2016, Thomas Engelbrecht Nordkild Jonassen has joined the board of directors of ResoTher Pharma A/S.
As of July 4, 2016, Thomas Engelbrecht Nordkild Jonassen is registered as adm. dir. of ResoTher Pharma A/S.
ResoTher Pharma A/S was founded on July 4, 2016.
Companies in the same industry and area
CVR 34586519
CVR 25569733
CVR 41634774
CVR 36051183
CVR 40979603
